Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,713 evidence items · page 27 / 69

10,175 EU/mLGeometric mean titres of IgG antibodies to the circumsporozoite antigen in infants were 10175 (7724 to 13404) EU/mL at day 84.

Kenyapaludismepublished 2023Wellcome open researcheurope_pmcdocument of 3 observations

1,500,000 deaths_per_yearMalaria kills between 1 and 2 million people each year.

Kenyapaludismepublished 2002Natureeurope_pmc

2 per_habitatThe mean density of An. squamosus was 2.0 in tire tracks in Kakamega County, western Kenya between March and June 2019.

Kenyapaludismeobserved March and June 2019published 2021Ethiopian journal of health sciencesPubMeddocument of 8 observations

3 daysThe mean length of stay for patients admitted with a malaria diagnosis was three days.

Kenyapaludismeobserved June 2016 to May 2017published 2021Malaria journalPubMeddocument of 11 observations

No resistant mutations in Pfk13 were found in Plasmodium falciparum parasites from Asembo, Kenya.

Kenyapaludismepublished 2022Malaria journalPubMeddocument of 10 observations

-0.718 correlation_coefficientHaematocrit correlated negatively with red cell distribution width in malaria-infected children with HbSS genotype (r = -0.718, P = 0.009).

Kenyapaludismepublished 2021BMC infectious diseasesPubMeddocument of 13 observations

4.09 odds_ratioHighland residents who had traveled were more likely to have Plasmodium infection at the time of interview than highland residents who had not traveled, with an adjusted odds ratio of 4.09.

Kenyapaludismeobserved 2015published 2022Travel medicine and infectious diseasePubMeddocument of 3 observations

44.1 %The secondary endpoint of receipt of antimalarial treatment in the presence of parasitaemia of any density was reached in 49/111 (44.1%) non-Dantu subjects.

Kenyapaludismepublished 2022Controlled Human Malaria Infection reveals that the Dantu blood group variant provides higeurope_pmcdocument of 6 observationsDOI 10.1101/2022.09.21.22280031

21 deathsThe risk of dying between the ages of 5 years and 10 years was no higher among children who had received chemoprophylaxis with Maloprim than among children who had received placebo, with 21 deaths in the Maloprim group and 24 deaths in the placebo group.

Kenyapaludismepublished 1995Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 3 observations

1.3 %Pfs25 exhibited low mutation frequencies ranging from 1.3% to 7.7%.

Kenyapaludismepublished 2022PloS onePubMeddocument of 6 observations

1 US dollars_per_person_per_yearInternational malaria funding allocation is less than US$1 per person at risk per year.

Kenyapaludismepublished 2008PLoS medicineeurope_pmcdocument of 5 observations

0.74 aIRRStandard LLINs plus annual IRS was more effective than standard LLINs alone at 1-6 months post-intervention (adjusted incidence rate ratio 0.74).

Kenyapaludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations

5,000,000,000 clinical_episodes_per_yearAlmost 5 billion clinical episodes resembling malaria occur in endemic areas annually.

Kenyapaludismepublished 2006Conquering Malariaeurope_pmcdocument of 6 observations

1.7 %Pfk13 A675V mutation associated with artemisinin resistance was present as mixed genotype infections in 2 samples (1.7%) among primary school-going children in 15 counties in Kenya.

Kenyapaludismepublished 2025BMC infectious diseasesPubMeddocument of 6 observations

13 false_negativesAt Siaya County Referral Hospital, there were 13 false negatives by routine microscopy compared to malachite green loop-mediated isothermal amplification (MG-LAMP).

Kenyapaludismepublished 2020Malaria journalPubMeddocument of 17 observations

91.7 %The use of the four-tests panel improved data management for the four infections by 91.7% in selected Primary Health Care facilities in Kenya.

Kenyahépatite B · paludisme · syphilis · VIH/sidapublished 2024Frontiers in public healthPubMeddocument of 15 observations

22 %The K65Q mutant allele was detected at a frequency of 22% in recurrent malaria infection samples.

Kenyapaludismepublished 2023Malaria journalPubMeddocument of 5 observations

0.89 aIRRAdding annual IRS to PBO nets was more effective than supplementing with larviciding at 13-18 months post-intervention among stage 1 non-responding clusters (adjusted incidence rate ratio 0.89).

Kenyapaludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations

19.7 %Infection prevalence was 19.7% in cross-sectional mass blood screening of children aged 5 to 15 years in Chulaimbo, Kisumu, during the dry and wet seasons in 2018 and 2019.

Kenyapaludismeobserved 2018 and 2019published 2025Scientific reportsPubMeddocument of 10 observations

25 %The conclusion states that in settings typical of sub-Saharan Africa, one-quarter of WHO-defined pneumonia cases are malaria rather than pneumonia.

Kenyapaludismepublished 2025International journal of epidemiologyeurope_pmcdocument of 8 observations

1.12 mortality_rate_ratioIncrease in rainfall was associated with increased malaria mortality (mortality rate ratio = 1.12, 95% Bayesian credible interval: 1.04–1.20).

Kenyapaludismeobserved 2008–2019published 2024BMJ global healthPubMeddocument of 8 observations

14 false_positivesAt Rota Dispensary, there were 14 false positives and 29 false negatives by rapid diagnostic test (RDT) compared to malachite green loop-mediated isothermal amplification (MG-LAMP).

Kenyapaludismepublished 2020Malaria journalPubMeddocument of 17 observations

44 %The introduction of insecticide treated bednets led to a 44% reduction in severe, life-threatening malaria among children aged 1-59 months.

Kenyapaludismeobserved 1993–1995published 1996Tropical medicine & international health : TM & IHeurope_pmcdocument of 3 observations

33 %The introduction of insecticide treated bednets led to a 33% reduction in childhood mortality among children aged 1-59 months.

Kenyapaludismeobserved 1993–1995published 1996Tropical medicine & international health : TM & IHeurope_pmcdocument of 3 observations

EDCTP funds clinical trial interventions to fight HIV/AIDS, malaria, and tuberculosis in the sub-Saharan African region.

Kenyapaludisme · tuberculose · VIH/sidapublished 2009BMC public healtheurope_pmcdocument of 4 observationsDOI 10.1186/1471-2458-9-249

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.